It is also noteworthy that PSMB9 expression is up-regulated by GCS overexpression in ovarian cancer, and is associated with cancer resistance to platinum-based chemotherapy (Figure 5A) [35]. This evidence concerns the gene PSMB9 and ovarian carcinoma.